SIM-0506

N/A

Report date: 2024/08/15 17:13:05
NME

Base Information

Drug NameSIM-0506
Drug Alias NameSIM-0506
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSon of sevenless homolog 1 inhibitors
TargetsSon of sevenless homolog 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSimcere Pharmaceutical Group Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHainan Xiansheng Re Ming Pharmaceutical Co LtdShanghai Xiansheng Zaiming Pharmaceutical Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A